Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Limited | RDY | $13.19 | $10.99B | 30.0 | 0.63% |
| Universal Health Services, Inc. | UHS | $182.87 | $10.78B | 7.5 | 0.43% |
| Align Technology, Inc. | ALGN | $151.37 | $10.75B | 26.3 | — |
| BioMarin Pharmaceutical Inc. | BMRN | $55.21 | $10.69B | 149.2 | — |
| Madrigal Pharmaceuticals, Inc. | MDGL | $457.96 | $10.58B | — | |
| Globus Medical, Inc. | GMED | $78.68 | $10.56B | 20.2 | — |
| Glaukos Corporation | GKOS | $176.85 | $10.43B | — | |
| Qiagen N.V. | QGEN | $50.00 | $10.32B | 25.4 | 0.72% |
| Oscar Health, Inc. | OSCR | $33.45 | $10.32B | 25.9 | — |
| The Ensign Group, Inc. | ENSG | $173.35 | $10.10B | 27.2 | 0.15% |
| Vaxcyte, Inc. | PCVX | $63.23 | $9.95B | — | |
| Twist Bioscience Corporation | TWST | $149.13 | $9.89B | — | |
| 10x Genomics, Inc. | TXG | $75.59 | $9.85B | — | |
| Insulet Corporation | PODD | $141.90 | $9.84B | 26.6 | — |
| Krystal Biotech, Inc. Common Stock | KRYS | $322.17 | $9.54B | 40.4 | — |
| Henry Schein, Inc. | HSIC | $85.01 | $9.47B | 24.8 | — |
| Bio-Rad Laboratories, Inc. | BIO | $360.50 | $9.43B | 44.7 | — |
| Kymera Therapeutics, Inc. | KYMR | $112.63 | $9.26B | — | |
| ImmunityBio, Inc. | IBRX | $8.64 | $9.16B | — | |
| Hinge Health, Inc. | HNGE | $112.00 | $9.04B | 37.0 | — |
| Protagonist Therapeutics, Inc. | PTGX | $138.08 | $8.93B | 134.1 | — |
| Cytokinetics, Incorporated | CYTK | $62.86 | $8.74B | — | |
| Spyre Therapeutics, Inc. | SYRE | $92.95 | $8.69B | — | |
| Bruker Corporation | BRKR | $59.11 | $8.56B | 0.36% | |
| Axsome Therapeutics, Inc. | AXSM | $156.31 | $8.36B | — | |
| Caris Life Sciences, Inc. | CAI | $32.35 | $8.35B | 17.5 | — |
| Arrowhead Pharmaceuticals, Inc. | ARWR | $58.84 | $8.31B | — | |
| ABIVAX Société Anonyme | ABVX | $93.49 | $8.16B | — | |
| TG Therapeutics, Inc. | TGTX | $53.20 | $8.14B | 19.4 | — |
| HealthEquity, Inc. | HQY | $97.88 | $8.10B | 35.3 | — |
| AptarGroup, Inc. | ATR | $125.63 | $7.99B | 22.7 | 1.53% |
| Apotex Health Corp. | APTX.TO | CA$33.23 | CA$7.59B | 0.18% | |
| PACS Group, Inc. | PACS | $46.76 | $7.40B | 27.4 | — |
| Ionis Pharmaceuticals, Inc. | IONS | $44.27 | $7.36B | — | |
| Alkermes plc | ALKS | $43.48 | $7.29B | 114.4 | — |
| Praxis Precision Medicines, Inc. | PRAX | $256.47 | $7.16B | — | |
| Amneal Pharmaceuticals, Inc. | AMRX | $20.20 | $7.04B | 41.2 | — |
| Hims & Hers Health, Inc. | HIMS | $29.21 | $6.82B | — | |
| Iovance Biotherapeutics, Inc. | IOVA | $14.62 | $6.62B | — | |
| Lantheus Holdings, Inc. | LNTH | $100.24 | $6.55B | 24.3 | — |
| Chemed Corporation | CHE | $511.37 | $6.55B | 25.2 | 0.56% |
| Ligand Pharmaceuticals Incorporated | LGND | $314.78 | $6.28B | 33.2 | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | $79.70 | $6.22B | 80.5 | — |
| Belite Bio, Inc | BLTE | $153.18 | $6.15B | — | |
| Rhythm Pharmaceuticals, Inc. Common Stock | RYTM | $88.62 | $6.10B | — | |
| Doximity, Inc. | DOCS | $33.58 | $5.99B | 39.5 | — |
| GRAIL, Inc. | GRAL | $132.60 | $5.92B | — | |
| Immunovant, Inc. | IMVT | $28.38 | $5.86B | — | |
| Bausch + Lomb Corporation | BLCO | $17.18 | $5.73B | — | |
| Veradermics, Incorporated | MANE | $136.66 | $5.71B | — |
Dr. Reddy's Laboratories Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $10.99B
- P/E
- 30.0
- Dividend Yield
- 0.63%
Universal Health Services, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $10.78B
- P/E
- 7.5
- Dividend Yield
- 0.43%
Align Technology, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $10.75B
- P/E
- 26.3
BioMarin Pharmaceutical Inc.
Healthcare / Biotechnology
- Market Cap
- $10.69B
- P/E
- 149.2
Madrigal Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $10.58B
- P/E
- unprofitable
Globus Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $10.56B
- P/E
- 20.2
Glaukos Corporation
Healthcare / Medical Devices
- Market Cap
- $10.43B
- P/E
- unprofitable
Qiagen N.V.
Healthcare / Diagnostics & Research
- Market Cap
- $10.32B
- P/E
- 25.4
- Dividend Yield
- 0.72%
Oscar Health, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $10.32B
- P/E
- 25.9
The Ensign Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $10.10B
- P/E
- 27.2
- Dividend Yield
- 0.15%
Vaxcyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.95B
- P/E
- unprofitable
Twist Bioscience Corporation
Healthcare / Biotechnology
- Market Cap
- $9.89B
- P/E
- unprofitable
10x Genomics, Inc.
Healthcare / Medical Devices
- Market Cap
- $9.85B
- P/E
- unprofitable
Insulet Corporation
Healthcare / Medical Devices
- Market Cap
- $9.84B
- P/E
- 26.6
Krystal Biotech, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $9.54B
- P/E
- 40.4
Henry Schein, Inc.
Healthcare / Medical Distribution
- Market Cap
- $9.47B
- P/E
- 24.8
Bio-Rad Laboratories, Inc.
Healthcare / Medical Devices
- Market Cap
- $9.43B
- P/E
- 44.7
Kymera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.26B
- P/E
- unprofitable
ImmunityBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.16B
- P/E
- unprofitable
Hinge Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $9.04B
- P/E
- 37.0
Protagonist Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.93B
- P/E
- 134.1
Cytokinetics, Incorporated
Healthcare / Biotechnology
- Market Cap
- $8.74B
- P/E
- unprofitable
Spyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.69B
- P/E
- unprofitable
Bruker Corporation
Healthcare / Medical Devices
- Market Cap
- $8.56B
- P/E
- unprofitable
- Dividend Yield
- 0.36%
Axsome Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.36B
- P/E
- unprofitable
Caris Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.35B
- P/E
- 17.5
Arrowhead Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.31B
- P/E
- unprofitable
ABIVAX Société Anonyme
Healthcare / Biotechnology
- Market Cap
- $8.16B
- P/E
- unprofitable
TG Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.14B
- P/E
- 19.4
HealthEquity, Inc.
Healthcare / Health Information Services
- Market Cap
- $8.10B
- P/E
- 35.3
AptarGroup, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $7.99B
- P/E
- 22.7
- Dividend Yield
- 1.53%
Apotex Health Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$7.59B
- P/E
- unprofitable
- Dividend Yield
- 0.18%
PACS Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $7.40B
- P/E
- 27.4
Ionis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $7.36B
- P/E
- unprofitable
Alkermes plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $7.29B
- P/E
- 114.4
Praxis Precision Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $7.16B
- P/E
- unprofitable
Amneal Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $7.04B
- P/E
- 41.2
Hims & Hers Health, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.82B
- P/E
- unprofitable
Iovance Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.62B
- P/E
- unprofitable
Lantheus Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.55B
- P/E
- 24.3
Chemed Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $6.55B
- P/E
- 25.2
- Dividend Yield
- 0.56%
Ligand Pharmaceuticals Incorporated
Healthcare / Biotechnology
- Market Cap
- $6.28B
- P/E
- 33.2
Kiniksa Pharmaceuticals International, plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.22B
- P/E
- 80.5
Belite Bio, Inc
Healthcare / Biotechnology
- Market Cap
- $6.15B
- P/E
- unprofitable
Rhythm Pharmaceuticals, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $6.10B
- P/E
- unprofitable
Doximity, Inc.
Healthcare / Health Information Services
- Market Cap
- $5.99B
- P/E
- 39.5
GRAIL, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $5.92B
- P/E
- unprofitable
Immunovant, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.86B
- P/E
- unprofitable
Bausch + Lomb Corporation
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.73B
- P/E
- unprofitable
Veradermics, Incorporated
Healthcare / Biotechnology
- Market Cap
- $5.71B
- P/E
- unprofitable
Showing 101–150 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.